Plethysmography as a Complementary Tool for Monitoring Response to CFTR Modulator Therapy in Children with Cystic Fibrosis: A Real-World Study
- 1Cystic Fibrosis Department, Institute of Mother and Child, 01-211 Warsaw, Poland
- 2Cystic Fibrosis Centre, Paediatric Hospital, 05-092 Dziekanów Leśny, Poland
Abstract
Background: Sensitive tools for monitoring response to cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy remain needed in children with cystic fibrosis (CF). Plethysmography may provide complementary information to spirometry and multiple-breath nitrogen washout (MBNW). Aim: To characterize longitudinal changes in plethysmographic parameters before and during CFTR modulator therapy in children and adolescents with CF, using spirometry and MBNW as complementary physiological assessments. Methods: This retrospective observational study included 67 children with CF. Forty-nine patients received elexacaftor/tezacaftor/ivacaftor (ETI) and 18 received tezacaftor/ivacaftor (TI). Spirometry, plethysmography, and MBNW were performed at baseline and at follow-up, typically 12 months after treatment initiation, but no later than 24 months. Health-related quality of life was assessed using the Cystic Fibrosis Questionnaire–Revised (CFQ-R) in 42 ETI-treated patients with complete paired data. Pulmonary exacerbations requiring intravenous antibiotic treatment were also analyzed. Results: During ETI treatment, significant within-group changes were observed in forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), lung clearance index (LCI2.5), airway resistance, total lung capacity (TLC), and the residual volume-to-total lung capacity ratio (RV/TLC). Improvements in selected CFQ-R domains and a reduction in pulmonary exacerbations requiring intravenous antibiotics were also observed in the ETI group, although the between-group difference in exacerbation changes was not statistically significant. Conclusions: Plethysmography, particularly airway resistance and RV/TLC, may provide complementary information to spirometry and MBNW when monitoring pulmonary function changes during CFTR modulator therapy in pediatric CF.
Related
- Restrictive lung function defined by body plethysmography is common in children with Fontan palliation and functionally relevant
- Rectal diameter measured by transabdominal ultrasonography for monitoring treatment response in children with functional constipation
- Hybrid circular-square complementary split-ring resonator sensor for monitoring abnormal blood protein levels for disease diagnosis
- Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer
- Interactive Social Media-Based Nutrition Education to Improve Complementary Feeding Practices for Mothers with Underweight Children
BibTeX
@article{postek2026plethysmography,
title = {{Plethysmography as a Complementary Tool for Monitoring Response to CFTR Modulator Therapy in Children with Cystic Fibrosis: A Real-World Study}},
author = {Magdalena Aleksandra Postek and Katarzyna Walicka-Serzysko and Urszula Borawska-Kowalczyk and Justyna Milczewska and Katarzyna Zybert and Anna Wołkowicz and Łukasz Woźniacki and Dorota Sands},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218356},
url = {https://www.mdpi.com/2077-0383/15/21/8356},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Plethysmography as a Complementary Tool for Monitoring Response to CFTR Modulator Therapy in Children with Cystic Fibrosis: A Real-World Study
AU - Magdalena Aleksandra Postek
AU - Katarzyna Walicka-Serzysko
AU - Urszula Borawska-Kowalczyk
AU - Justyna Milczewska
AU - Katarzyna Zybert
AU - Anna Wołkowicz
AU - Łukasz Woźniacki
AU - Dorota Sands
PY - 2026
DA - 2026/10/27
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218356
UR - https://www.mdpi.com/2077-0383/15/21/8356
AB - Background: Sensitive tools for monitoring response to cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy remain needed in children with cystic fibrosis (CF). Plethysmography may provide complementary information to spirometry and multiple-breath nitrogen washout (MBNW). Aim: To characterize longitudinal changes in plethysmographic parameters before and during CFTR modulator therapy in children and adolescents with CF, using spirometry and MBNW as complementary physiological assessments. Methods: This retrospective observational study included 67 children with CF. Forty-nine patients received elexacaftor/tezacaftor/ivacaftor (ETI) and 18 received tezacaftor/ivacaftor (TI). Spirometry, plethysmography, and MBNW were performed at baseline and at follow-up, typically 12 months after treatment initiation, but no later than 24 months. Health-related quality of life was assessed using the Cystic Fibrosis Questionnaire–Revised (CFQ-R) in 42 ETI-treated patients with complete paired data. Pulmonary exacerbations requiring intravenous antibiotic treatment were also analyzed. Results: During ETI treatment, significant within-group changes were observed in forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), lung clearance index (LCI2.5), airway resistance, total lung capacity (TLC), and the residual volume-to-total lung capacity ratio (RV/TLC). Improvements in selected CFQ-R domains and a reduction in pulmonary exacerbations requiring intravenous antibiotics were also observed in the ETI group, although the between-group difference in exacerbation changes was not statistically significant. Conclusions: Plethysmography, particularly airway resistance and RV/TLC, may provide complementary information to spirometry and MBNW when monitoring pulmonary function changes during CFTR modulator therapy in pediatric CF.
SN - 2077-0383
ER -